Publications

Consensus and Disagreement Among Experts in Treatment of Patients With HER2+ Early-Stage Breast Cancer

Treatment options for HER2+ EBC are continuing to evolve, increasing the complexity of treatment decision making. As treatment options expand, so does the need for online decision aids. The aim of this analysis was to assess real-world global practice patterns for HER2+ EBC and compare them with recommendations from US experts based on patient cases entered by healthcare providers into an online decision support tool designed to provide specific, patient-individualized expert recommendations.

 

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?